Biotechblog

GlaxoSmithKline Reveals Ingenuity

September 23, 2003 Comments Off Posted in: General Biotechnology

GlaxoSmithKline Reveals Ingenuity In a further validation of Big Pharma�s acceptance of systems biology, GlaxoSmithKline has licensed part of the Ingenuity Pathways Knowledge Base to facilitate genome-wide computational analysis of biological systems underlying disease.

The Best in Drugs and Biotech

September 22, 2003 Comments Off Posted in: General Biotechnology

The Best in Drugs and Biotech: “S&P’s Herman Saftlas and Frank DiLorenzo share some favorites in these resurgent sectors, including Barr Pharmaceuticals and MedImmune “